-
Effect of Losartan and A779 on myocardial interstitial fibrosis in diabetic cardiomyopathy
- HU Sheng,ZHANG Xu-hong,DONG Bo,ZHU Mei,ZHANG Yue-hui,YU Qing-tao
-
JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES). 2008, 46(4):
362-365.
-
Abstract
(
1364 )
PDF (325KB)
(
518
)
Save
-
Related Articles |
Metrics
To investigate the effect of Losartan and A779 on myocardial interstitial fibrosis in diabetic cardiomyopathy (DCM). MethodsThirtynine male Wistar rats were intraperitoneally injected with streptozocin (STZ) once to induce hyperglycemia. After 12 weeks of STZ injection, rats whose blood glucose was higher than 16.7mmol/L and who had polydipsia, hyperphagia and polyuria were randomly divided into 3 groups: the DCM group, the losartan group and the A779+Losartan group. The DCM group was subjected to perfusion of normal saline into the stomach once daily, the losartan group perfusion of losartan once daily, and the A779+Losartan group perfusion of losartan and injection of A779 through the tail vein once daily. At the end of the experiment, LVIDs, LVIDd, E/A, LVEF and FS were determined by ultrasound. Then the collagen level was determined by Masson staining, and the mRNA expression of angiotensinconvertion enzyme 2 (ACE2) was determined by real-time RT-PCR. ResultsBy the end of the experiment, the LVIDs, LVIDd and the collagen level of the losartan group and the A779+Losartan group were lower than those of the DCM group (P<0.01), also the E/A, FS, LVEF levels and the expression of ACE2 mRNA of the losartan group and the A779+Losartan group were higher than those of the DCM group(P<0.01). The LVIDs, LVIDd and collagen content of the A779+Losartan group were higher than those of the losartan group(P<0.05), and E/A, FS and LVEF of the A779+Losartan group were lower than those of the losartan group(P<0.05). However the expression of ACE2 mRNA had no difference between the losartan group and the A779+Losartan group. ConclusionsLosartan amelioorates the myocardial interstitial fibrosis via Ang-(1.7).